We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+11.11%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$218B
AUM Growth
-$5.41B
Cap. Flow
-$25.1B
Cap. Flow %
-11.51%
Top 10 Hldgs %
47.1%
Holding
5,603
New
345
Increased
2,379
Reduced
1,667
Closed
541

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1.82B
2
AAPL icon
Apple
AAPL
+$1.62B
3
UNH icon
UnitedHealth
UNH
+$1.03B
4
XOM icon
ExxonMobil
XOM
+$869M
5
TSLA icon
Tesla
TSLA
+$701M

Sector Composition

Rank Sector Weight
1 Technology 12.19%
2 Consumer Discretionary 5.03%
3 Healthcare 4.78%
4 Financials 4.74%
5 Communication Services 2.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KRO icon
4001
KRONOS Worldwide
KRO
$693M
$107K ﹤0.01%
11,666
+5,217
+81% +$54.8K
NKTR icon
4002
Nektar Therapeutics
NKTR
$2.39B
$107K ﹤0.01%
10,184
-743
-7% -$22.5K
MVBF icon
4003
MVB Financial
MVBF
$397M
$107K ﹤0.01%
5,172
+2,422
+88% +$56.2K
FRST icon
4004
Primis Financial Corp
FRST
$399M
$107K ﹤0.01%
11,075
+5,125
+86% +$58K
RRBI icon
4005
Red River Bancshares
RRBI
$662M
$106K ﹤0.01%
2,206
+1,034
+88% +$51.2K
ACET icon
4006
Adicet Bio
ACET
$85.2M
$106K ﹤0.01%
1,146
-5,020
-81% -$630K
ULH icon
4007
Universal Logistics Holdings
ULH
$353M
$106K ﹤0.01%
3,622
+1,693
+88% +$54.9K
ALTO icon
4008
Alto Ingredients
ALTO
$369M
$106K ﹤0.01%
70,377
-17,272
-20% -$47.3K
GHIXW
4009
DELISTED
Gores Holdings IX, Inc. Warrant
GHIXW
$105K ﹤0.01%
458,333
ABOS icon
4010
Acumen Pharmaceuticals
ABOS
$155M
$105K ﹤0.01%
25,952
-8,509
-25% -$44.4K
AFCG
4011
AFC Gamma
AFCG
$61.4M
$105K ﹤0.01%
12,643
+5,659
+81% +$57.5K
NETI
4012
DELISTED
Eneti Inc.
NETI
$105K ﹤0.01%
11,196
+5,250
+88% +$52.5K
CONN
4013
DELISTED
Conn's Inc.
CONN
$104K ﹤0.01%
17,107
+8,642
+102% +$73.6K
AKTS
4014
DELISTED
Akoustis Technologies Inc
AKTS
$103K ﹤0.01%
33,602
+19,309
+135% +$67.4K
RMNI icon
4015
Rimini Street
RMNI
$449M
$103K ﹤0.01%
25,082
+11,830
+89% +$53.3K
HHLA.WS
4016
DELISTED
HH&L Acquisition Co. Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50
HHLA.WS
$103K ﹤0.01%
10,000
TAC icon
4017
TransAlta
TAC
$3.95B
$103K ﹤0.01%
11,800
+1,800
+18% +$15.9K
ROCL
4018
DELISTED
Roth CH Acquisition V Co. Common Stock
ROCL
$103K ﹤0.01%
10,000
LXRX icon
4019
Lexicon Pharmaceuticals
LXRX
$1.03B
$103K ﹤0.01%
42,296
+19,936
+89% +$45.7K
CMBM
4020
DELISTED
Cambium Networks
CMBM
$103K ﹤0.01%
5,797
+2,712
+88% +$55.2K
WKHS icon
4021
Workhorse Group
WKHS
$33.2M
$103K ﹤0.01%
26
+12
+86% +$66.2K
CLSK icon
4022
CleanSpark
CLSK
$3.53B
$103K ﹤0.01%
36,944
+24,691
+202% +$67.8K
BSX.PRA
4023
DELISTED
Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A
BSX.PRA
$103K ﹤0.01%
848
-17,674
-95% -$2.03M
IMUX icon
4024
Immunic
IMUX
$190M
$102K ﹤0.01%
6,874
-1,063
-13% -$19.7K
NESR
4025
National Energy Services Reunited Corp
NESR
$2.72B
$102K ﹤0.01%
19,437
+9,194
+90% +$60.7K

Similar funds

Barclays's Q1 2023 Portfolio in Review

As of Q1 2023, Barclays held 5,603 positions worth $218B, down 2.4% from $223B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Barclays withdrew a net $25.1B in Q1 2023, closing 541 positions and reducing 1,667 holdings. Its most notable exit was Coupa Software Incorporated, an estimated $128M position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Barclays opened a new position in GE HealthCare worth $40.7M.

  • Barclays's largest Q1 2023 buy was GE HealthCare: 496,712 shares worth $40.7M.
  • Barclays added most to State Street SPDR S&P Biotech ETF in Q1 2023, an estimated $284M increase.
  • Barclays's biggest Q1 2023 reduction was Microsoft, cutting an estimated $1.82B.
  • Barclays fully exited Coupa Software Incorporated in Q1 2023, selling an estimated $128M.
  • Barclays's ten largest holdings make up 47% of its $218B portfolio in Q1 2023.
  • Barclays opened 345 new positions and closed 541 in Q1 2023.
  • Barclays's portfolio value fell 2.4% quarter-over-quarter to $218B.

Based on Barclays's 13F filing for Q1 2023, filed 4 May 2023.